PPT-Darunavir/r Monotherapy versus Triple Therapy

Author : eve | Published Date : 2023-07-21

PROTEA Trial Darunavirr M onotherapy versus Triple Therapy PROTEA Study Design Source Antinori A et al J Int AIDS Soc 20141719525 Darunavir 800 mg QD Ritonavir

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Darunavir/r Monotherapy versus Triple Th..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Darunavir/r Monotherapy versus Triple Therapy: Transcript

PROTEA Trial Darunavirr M onotherapy versus Triple Therapy PROTEA Study Design Source Antinori A et al J Int AIDS Soc 20141719525 Darunavir 800 mg QD Ritonavir 100 mg QD. Dr. . Sengottuvel. . Viswanathan. Delhi University. Delhi. Epilepsy- recurrent seizures due to chronic underlying process. Incidence is 5 to 7 per 10,000 children .. 5 among 1,000 children have epilepsy .. monotherapy. MONOI. MONET. PROTEA. DRV600. Design. Objective. Non inferiority in the proportion of patients with HIV-1 RNA < 50 c/. mL. at W48 (ITT analysis, missing/discontinuation/switch= failure, snapshot algorithm. Dr. . Sengottuvel. . Viswanathan. Delhi University. Delhi. Epilepsy- recurrent seizures due to chronic underlying process. Incidence is 5 to 7 per 10,000 children .. 5 among 1,000 children have epilepsy .. PharmD. PGY1 Pharmacy Resident . Baptist Health Medical Center- North Little Rock . September 27. th. . 2016. HAP and VAP. Guidelines Update. Objectives. Outline. Major differences introduced in the 2016 guidelines. Dolutegravir monotherapy vs. dolutegravir/ abacavir / lamivudine for HIV-1-infected virologically suppressed patients: results from the randomized non- inferiority MONCAY trial L. Hocqueloux Joseph J. Eron, Jr, MD. Professor of Medicine. University of North Carolina. Chapel Hill, North Carolina. Panelists. Constance Benson. Hyman Scott. Annie . Luetkemeyer. Robert . Schooley. Financial Relationships With Commercial Entities. DUAL-GESIDA. Dual Maintenance ART with RTV-Boosted Darunavir + . Lamivudine. DUAL . GESIDA: . Study Design. Source: . Pulido. . F, . et al. . Clin Infect . Dis.. . 2017;65:2112-8.. DRV + RTV + 3TC. Lopinavir. -RTV in Treatment Experienced. TITAN Trial. Darunavir/. r . versus Lopinavir/r in Treatment-Experienced . TITAN. : Study Design. Source: . Madruga. JV, et al. Lancet. 2007;370:49-58. . Darunavir. FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs . FLAMINGO: Study Design. Source: . Clotet. B, et al. . Lancet. 2014;383:2222-31. . Dolutegravir + . TDF-FTC or ABC-3TC. (n = 242). Darunavir + Ritonavir + . POTENT Trial. Tipranavir. /. r . versus Darunavir. /r . in Treatment-Experienced . POTENT. : Study Design. Source: . Elgadi. MM, et al. . Drugs R D. . 2011;11:. 295-. 302.. Tipranavir. . + . R. itonavir BID . breast. . cancer. . needs. . different. . therapeutic. . strategies. . than. HER-2 . enriched. . tumors. ?. Patrizia Vici. Cleopatra. TDM-1: . EMILIA. Verma. S ESMO 2012. (. Activity. . HR+. POWER 1 and 2. Darunavir. /. r versus other PIs in Treatment-Experienced . POWER 1 and 2. : Study Design. Source: . Clotet. B, et al. . Lancet. . 2007;369:. 1169-78.. Darunavir BID + RTV BID + OBR . RADAR Trial. Raltegravir. + Darunavir/r versus TDF-FTC + Darunavir/r. RADAR: Study Design. Source: . Bedimo. RJ, et al. . PLoS. One. 2014;9:e106221.. Darunavir QD + Ritonavir QD + Raltegravir BID . NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir versus Darunavir/r + TDF-FTC. NEAT001/ANRS143: Study Design. Source: . Raffi. F, et al. Lancet. 2014;384:1942-51. .. Darunavir + Ritonavir QD. + Raltegravir BID .

Download Document

Here is the link to download the presentation.
"Darunavir/r Monotherapy versus Triple Therapy"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.